Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

NCT04080531 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

165

Enrollment

OTHER

Sponsor class

Conditions

Plasma Cell Neoplasm

Interventions

BIOLOGICAL: Pneumococcal 13-valent Conjugate Vaccine
BIOLOGICAL: Trivalent Influenza Vaccine

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]